Picture of Pila Pharma AB logo

PILA — Pila Pharma AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Pila Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Interim ReportInterim ReportARSARSARS
Standards:
SAS
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6.98-17.2-9.93-11.2-17
Non-Cash Items3.627.944.574.169.83
Other Non-Cash Items
Changes in Working Capital1.36-0.0930.502-0.7390.543
Change in Accounts Receivable
Change in Accounts Payable
Change in Other Liabilities
Cash from Operating Activities-2-9.36-4.85-7.82-6.63
Capital Expenditures0000—
Purchase of Fixed Assets
Other Investing Cash Flow Items0000—
Sale of Fixed Assets
Cash from Investing Activities0000—
Financing Cash Flow Items-3.6-7.92-3.5-3.08-12.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.15835.73.566.7617.6
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2.1626.3-1.29-1.0611